系统性硬化症相关的间歇性肺部疾病:改善了解和管理方面的进展
1Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
British journal of hospital medicine (London, England : 2005)
|December 24, 2025
概括
系统性硬化症相关的间歇性肺病 (SSc-ILD) 管理正在通过人工智能增强的成像,新的生物标志物如KL-6和更新的指导方针取得进展. 现在的治疗包括抗纤维素药物,免疫调节剂和组合疗法,以获得更好的患者结果.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 医疗成像医学成像
- 生物标志物 生物标志物
背景情况:
- 间歇性肺病 (ILD) 是系统性硬化症 (SSc) 的严重并发症,导致显著的发病率和死亡率,特别是在扩散性皮肤性SSc (dcSSc) 中.
- 早期发现和监测SSc-ILD对于有效管理至关重要.
- 最近的治疗进展扩大了SSc-ILD的治疗选择.
研究的目的:
- 综合目前的SSc-ILD的查,监测和治疗策略.
- 突出基于人工智能的诊断,血清生物标志物和更新的国际治疗指南的最新进展.
- 讨论新兴的组合和三重疗法方法,并提出未来的研究方向.
主要方法:
- 关于SSc-ILD诊断和治疗的最新文献的审查.
- 分析人工智能 (AI) 增强的高分辨率计算机断层扫描 (HRCT) 的进展.
- 血清生物标志物的评估,包括Krebs von den Lungen (KL) -6.
- 综合更新的国际准则 (ACR,CHEST,ATS,EULAR) 的综合.
主要成果:
- 人工智能增强的HRCT和KL-6等生物标志物有助于更早地检测和监测SSc-ILD.
- 抗纤维素药物 (例如,nintedanib) 和免疫调节剂 (例如,tocilizumab) 现在是已确定的治疗选择.
- 更新的指导方针反映了不断变化的治疗环境,包括组合疗法.
结论:
- 对于SSc-ILD的管理正在转向主动查,使用新型诊断和个性化治疗策略进行精确的监测.
- 组合和潜在的三重治疗方法代表了治疗SSc-ILD的重大进展.
- 未来的研究应该专注于生物标志物验证,机械洞察力和优化SSc-ILD个性化治疗计划.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:24Cystic Fibrosis: Management
438
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
438
01:26COPD: Management Using Bronchodilators and Corticosteroids
698
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
698
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:28Pleural Effusion II: Symptoms and Management
604
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
604
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K